Using Diagnostic Tools to Stage Breast Cancer
Not Applicable
Active, not recruiting
- Conditions
- Breast Cancer
- Registration Number
- NCT00367666
- Lead Sponsor
- University of Pennsylvania
- Brief Summary
This project is aimed at investigating the relative diagnostic and synergy of four state of the art breast imaging techniques (magnetic resonance imaging (MRI), full-field digital mammography (DMAM), ultrasound, and positron emission tomography (PET)) with respect to determining the extent of breast cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- Female
- Target Recruitment
- 400
Inclusion Criteria
- Women recently diagnosed with Breast Cancer
- Will be undergoing surgery (after study) at the Hospital of the University of Pennsylvania
Exclusion Criteria
- Contraindications to MRI
- previously diagnosed with breast cancer (in the smae breast) within the past 5 years
- Patients with known locally advanced cancer (prior to study entry) being treated with preoperative adjuvant therapy.
- Pregnant women
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States
University of Pennsylvania🇺🇸Philadelphia, Pennsylvania, United States